Vical Incorporated - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
VICL Nasdaq 2836 http://www.vical.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vical Incorporated

Factors of Influence in 2018, Key Indicators and Opportunity within Vical, Hilton Grand Vacations, Kemper, Franklin Financial Network, Perficient, and Westinghouse Air Brake Technologies — New Research Emphasizes Economic Growth - Aug 7th, 2018 6:25 am
Vical (VICL) Reports Q2 Loss, Tops Revenue Estimates - Aug 7th, 2018 5:55 am
Vical: 2Q Earnings Snapshot - Aug 7th, 2018 4:48 am
Vical Reports Second Quarter 2018 Financial and Operational Results - Aug 7th, 2018 4:30 am
Vical Announces Review of Potential Strategic Transactions - Jul 19th, 2018 4:00 am
When Will Vical Incorporated (NASDAQ:VICL) Become Profitable? - Jun 27th, 2018 9:18 am
Vical to scrap genital herpes treatment program after trial fails primary endpoint - Jun 11th, 2018 5:28 am
Vical Reports Phase 2 Trial of HSV-2 Therapeutic Vaccine Did Not Meet Primary Endpoint - Jun 11th, 2018 4:00 am
Does Vical Incorporated’s (NASDAQ:VICL) Past Performance Indicate A Weaker Future? - May 15th, 2018 6:35 pm
Edited Transcript of VICL earnings conference call or presentation 3-May-18 4:00pm GMT - May 8th, 2018 5:43 pm
Edited Transcript of VICL earnings conference call or presentation 15-Mar-18 4:00pm GMT - Mar 15th, 2018 9:11 pm
Vical Incorporated to Host Earnings Call - Mar 15th, 2018 7:00 am
Vical reports 4Q loss - Mar 15th, 2018 4:47 am